Goyang-si (1)

Seoul (1)

Anaplastic Large Cell Lymphoma, ALK-negative (1)

Angioimmunoblastic T Cell Lymphoma (1)

Cutaneous T Cell Lymphoma (1)

Peripheral T Cell Lymphoma Unspecified (1)

Completed (1)

phase 1/phase 2 (1)

Samsung Medical Center (1)

Asan Medical Center (1)

Korea Cancer Center Hospital (1)

National Cancer Center, Korea (1)

Yonsei University (1)

rad001 (everolimus) (1)

drug (1)

Other (1)

Interventional (1)

Peripheral T Cell Lymphoma Unspecified

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Mar 1, 2015